The DOI matches its Crossref record; 151 of the 152 references it cites were found in a registry or an index.
Hidradenitis Suppurativa: Where We Are and Where We Are Going
Open accessAbstract
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease primarily affecting apocrine gland-rich areas of the body. It is a multifactorial disease in which genetic and environmental factors play a key role. The primary defect in HS pathophysiology involves follicular occlusion of the folliculopilosebaceous unit, followed by follicular rupture and immune responses. Innate pro-inflammatory cytokines (e.g., IL-1β, and TNF-α); mediators of activated T helper (Th)1 and Th17 cells (e.g., IFN-γ, and IL-17); and effector mechanisms of neutrophilic granulocytes, macrophages, and plasma cells are involved. On the other hand, HS lesions contain anti-inflammatory mediators (e.g., IL-10) and show limited activity of Th22 cells. The inflammatory vicious circle finally results in pain, purulence, tissue destruction, and scarring. HS pathogenesis is still enigmatic, and a valid animal model for HS is currently not available. All these aspects represent a challenge for the development of therapeutic approaches, which are urgently needed for this debilitating disease. Available treatments are limited, mostly off-label, and surgical interventions are often required to achieve remission. In this paper, we provide an overview of the current knowledge surrounding HS, including the diagnosis, pathogenesis, treatments, and existing translational studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Progression leads to follicular rupture, with release of keratin, hair shaft fragments, and microbial products into the dermis [38,39].”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of dermal tunnels is particularly useful in established diseases and distinguishes hidradenitis suppurativa from simple folliculitis or isolated abscesses.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In more advanced lesions, the most characteristic and frequent histological finding is the presence of epithelium-lined sinus tracts or dermal tunnels, usually associated with chronic inflammation, granulation tissue, fibrosis, and scarring [38].”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ruptured follicles trigger a dense mixed inflammatory infiltrate composed of neutrophils, lymphocytes, plasma cells, macrophages, and foreign-body giant cells. These are frequently seen in early lesions.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [38]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Hidradenitis suppurativa is a chronic inflammatory disease characterized by painful nodules, abscesses, scarring, and a complex molecular and cellular landscape [38].”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [38]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180 · cited 1×
“In addition, a dysregulation of tryptophan catabolism (with overactivation of the kynurenine pathway and consequent stimulation of cytokines by inflammatory cell infiltrates) and of an aryl hydrocarbon receptor (AHR) (with impaired production of bacteria-derived AHR agonists and decreased incidence of AHR ligand-produ…”
BackgroundEuropean S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
Zouboulis, C. C., Desai, N., Emtestam, L., Hunger, R. E., Ioannides, D., Juhász, I., Lapins, J., Matusiak, L., Prens, E. P., Revuz, J., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12966 · Cited by 1,093 · cited 4×
“No unrestricted recommendation can be given for the use of conventional immunosuppressant or immunomodulatory drugs including prednisolone [103], dapsone [104], retinoids [105], and ciclosporin [106], amongst others, as there is little or conflicting evidence for their efficacy [63,98].”
BackgroundInfluentialTwo Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Kimball, A. B., Okun, M. M., Williams, D. A., Gottlieb, A. B., Papp, K. A., Zouboulis, C. C., Armstrong, A. W., Kerdel, F., Gold, M. H., Forman, S. B., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504370 · Cited by 807
Revuz, J. E., Canoui-Poitrine, F., Wolkenstein, P., Viallette, C., Gabison, G., Pouget, F., Poli, F., Faye, O., Roujeau, J. C., Bonnelye, G., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.06.020 · Cited by 627
Sabat, R., Jemec, G. B. E., Matusiak, Ł., Kimball, A. B., Prens, E., & Wolk, K. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0149-1 · Cited by 573
Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
Sartorius, K., Emtestam, L., Jemec, G. B. E., & Lapins, J. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09198.x · Cited by 525 · cited 3×
“Still today, the Hurley staging and the Sartorius scoring, together with HS Physician Global Assessment systems are the most commonly used assessment tools [22,23].”
BackgroundMethodZouboulis, C. C., Tzellos, T., Kyrgidis, A., Jemec, G. B. E., Bechara, F. G., Giamarellos‐Bourboulis, E. J., Ingram, J. R., Kanni, T., Karagiannidis, I., Martorell, A., et al. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15748 · Cited by 493
Hidradenitis Suppurativa: Advances in Diagnosis and Treatment
Saunte, D. M. L., & Jemec, G. B. E. (2017) · JAMA · doi:10.1001/jama.2017.16691 · Cited by 492 · cited 1×
“Independent of the duration and severity of HS, all patients should follow basic therapeutic measures, including self-education about the disease, pain management, maintaining high hygiene standards, cessation of smoking, and losing weight, amongst others [1,96].”
Backgroundvan der Zee, H. H., de Ruiter, L., van den Broecke, D. G., Dik, W. A., Laman, J. D., & Prens, E. P. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10254.x · Cited by 472 · cited 3×
“sion of NRLP3 as well as IL-1β were detected in HS lesions [75,77,78].”
Background
Cited by
Roy, T., Boateng, S. T., Uddin, M. B., Banang-Mbeumi, S., Yadav, R. K., Bock, C. R., Folahan, J. T., Siwe-Noundou, X., Walker, A. L., King, J. A., et al. (2023) · Cells · doi:10.3390/cells12121671 · Cited by 161
Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape
Krueger, J. G., Frew, J. W., Jemec, G. B. E., Kimball, A. B., Kirby, B., Bechara, F. G., Navrazhina, K., Prens, E. P., Reich, K., Cullen, E., et al. (2023) · British Journal of Dermatology · doi:10.1093/bjd/ljad345 · Cited by 132
Krajewski, P. K., Złotowska, A., & Szepietowski, J. C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216292 · Cited by 82
“…such as IL-1βand TNF-α, along with mediators from activated Th1 and Th17 helper cells (including IFN-γ and IL-17), and effector mechanisms involving neutrophils, and Th17 helper cells (including IFN-γ and IL-17), and effector mechanisms involving neutrophils, macrophages and plasma cells [17–19].”
BackgroundBurden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes
Kimball, A. B., Kirby, J. S., Ingram, J. R., Tran, T., Pansar, I., Ciaravino, V., Willems, D., Lewis-Mikhael, A.-M., Tongbram, V., & Garg, A. (2024) · Dermatology and Therapy · doi:10.1007/s13555-023-01085-w · Cited by 55
“HS can have a profound negative impact on patients’ health-related quality of life (HRQoL), mainly due to the high disease burden resulting from symptoms, delays in diagnosis limited access to appropriate disease management, and disease-related comorbidity profile [2–5].”
BackgroundPathogenesis of Inflammation in Skin Disease: From Molecular Mechanisms to Pathology
Shirley, S. N., Watson, A. E., & Yusuf, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810152 · Cited by 74
“Besides the associated pain and itching, the malodorous purulent discharge from ruptured follicles and the extensive scarring cause social embarrassment and isolation for many patients [55].”
Background
Metadata
- Authors
- Scala, E., Cacciapuoti, S., Garzorz-Stark, N., Megna, M., Marasca, C., Seiringer, P., Volz, T., Eyerich, K., & Fabbrocini, G.
- Affiliations
- Karolinska Institutet (SE)
- University of Naples Federico II (IT)
- Division of Dermatology and Venereology, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, 17176 Stockholm, Sweden
- Technical University of Munich (DE)
- Karolinska University Hospital (SE)
- Corresponding author
- Scala, Emanuele
- ORCID
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-08-15
- Volume
- 10
- Issue
- 8
- Pages
- 2094
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC8392140
- OpenAlex
- W3195421093
- Semantic Scholar
- 304c292cd74070067b2680ed72014e3741c3c074
- Cited by
- 135
- References
- 152
- Citations by year
- 2026: 24 · 2025: 31 · 2024: 31 · 2023: 27 · 2022: 20 · 2021: 2
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion, other-oa)
- Site cant be reached (submittedVersion, cc-by)
- Funders
- Technische Universität München
- Topics
- Health Sciences › Medicine › Dermatology › Hidradenitis Suppurativa and Treatments
- Health Sciences › Medicine › Dermatology › Autoimmune and Inflammatory Disorders
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- hidradenitis suppurativa, pathogenesis, follicular occlusion, apocrine glands, inflammatory cytokines, Th17 cells, Th22 cells, neutrophils, IL-17, TNF-α, IL-10, immune dysregulation, animal models, diagnosis, treatment, surgical treatment, chronic inflammatory skin disease
- MeSH terms
- Anti-Inflammatory Agents, Combined Modality Therapy, Humans, Inflammation, Skin, Biomarkers, Cytokines, Hidradenitis Suppurativa
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hidradenitis Suppurativa: Where We Are and Where We Are Going. https://app.cochat.ai/papers/10.3390/cells10082094
- The paper
- Scala, E., Cacciapuoti, S., Garzorz-Stark, N., Megna, M., Marasca, C., Seiringer, P., Volz, T., Eyerich, K., & Fabbrocini, G. (2021). Hidradenitis Suppurativa: Where We Are and Where We Are Going. Cells. https://doi.org/10.3390/cells10082094
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.